Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons from Carl M. Pearson 1919 - 1981.

James S Louie1

  • 1Rheumatology and Arthritis, UCLA, Los Angeles, CA, USA.

Rheumatic Diseases Clinics of North America
|November 16, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting inflammatory pathways in axial spondyloarthritis.

Arthritis research & therapy·2019
Same author

Genetic and inflammatory factors associated with psoriatic arthritis: Relevance to diagnosis and management.

Clinical immunology (Orlando, Fla.)·2019
Same author

Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2014
Same author

Different tumor necrosis factor α antagonists have different effects on host susceptibility to disseminated and oropharyngeal candidiasis in mice.

Virulence·2014
Same author

Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.

Arthritis care & research·2012
Same author

Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials.

Rheumatology (Oxford, England)·2010
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Pioneering physician Carl M. Pearson developed a key animal model for autoimmune diseases. His work with Freund's adjuvant in rats and mice advanced the study of inflammatory conditions like polyarthritis.

Area of Science:

  • Rheumatology
  • Immunology
  • Animal Models

Background:

  • Carl M. Pearson, a physician-scholar-leader, founded the Rheumatology Division at UCLA in 1956.
  • His research focused on understanding autoimmune disease mechanisms.

Purpose of the Study:

  • To investigate the induction of myositis and polyarthritis in animal models.
  • To establish a foundational model for studying autoimmune diseases and their therapies.

Main Methods:

  • Injection of muscle with heat-killed tubercle bacilli, emulsifier, and mineral oil (Freund's adjuvant) in specific rat and mice strains.
  • Observation of induced inflammatory responses, specifically polyarthritis.

Main Results:

  • Polyarthritis was observed to occur in certain rat and mice strains when treated with Freund's adjuvant alone.
Keywords:
HLA-B27MyositisUCLAUniversity of California in Los Angeles

Related Experiment Videos

  • This demonstrated the potential of Freund's adjuvant to induce autoimmune-like conditions.
  • Conclusions:

    • The Freund's adjuvant-induced arthritis model provides a valuable tool for studying autoimmune diseases.
    • Pearson's work laid the groundwork for future research into the pathogenesis and treatment of autoimmune disorders.